What is interesting about New Zealand's experience in regulating the sale of over-the-counter CBD products
Recognition of the possibility of using OTC cannabinoid products will give the cannabis industry momentum as it pushes the boundaries with the tight legal regulation of its activities, created in the early years of the danger of the cannabis market in the country. New Zealand journalists have become journalists based on research conducted in Canada, using the Australian experience, everything is possible in order to make small amounts of cannabidiol available to users without a prescription.
Just a month ago, on the page of the profile publication of their own cannabis growers, the issue of the ongoing “Steps to open the OTC CBD market in Canada” was raised. It is necessary to give away the officials involved in the hemp market of New Zealand, who promptly responded to the publication of the relevant Ministry of Health of Canada, initiating changes to the current legislation, according to the conditions in the country, it becomes possible to sell OTC CBD products. consideration of the reclassification of cannabidiol has been placed on the agenda of the New Zealand Drug Seizure Meeting (Medicin Classification Committee, MCC) to be held in late autumn of the year.
The New Zealand Medicines and Health Implications Authority (New Zealand Medicines and Medical Devices Safety Authority, Medsafe) proposes setting a daily human dose of cannabidiol at 150mg. In particular, the document describing the reason for the proposed changes states that "Medsafe requires the MCC to reconsider the classification of New Zealand detections upon arrival in the CBD."
Comment of experts of the "Ukrainian industrial hemp Association"
In New Zealand, as well as in Australia, any OTC CBD product must be registered and clinically tested in order to demonstrate its effectiveness. While any OTC CBD product in New Zealand will only be a few years away, the recognition of OTC cannabinoid products will give the cannabis industry a boost as it struggles to cope with the harsh regulatory environment that was created in the early years of the cannabis market. in the country. New Zealand officials, based on research conducted in Canada, using the Australian experience, are doing everything possible to ensure that small doses of cannabidiol become available for use by consumers without a prescription.
< Previous article Next article >